Boothbay Fund Management’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-1,345
| Closed | -$359K | – | 2466 |
|
|
2026
Q1 | $359K | Sell |
1,345
-990
| -42% | -$268K | ﹤0.01% | 1533 |
|
|
2025
Q4 | $586K | Buy |
+2,335
| New | +$620K | 0.01% | 1046 |
|
|
2024
Q2 | – | Sell |
-30,825
| Closed | -$6.73M | – | 1723 |
|
|
2024
Q1 | $6.73M | Buy |
+30,825
| New | +$6.79M | 0.13% | 151 |
|
|
2023
Q4 | – | Sell |
-8,709
| Closed | -$1.75M | – | 1838 |
|
|
2023
Q3 | $1.75M | Sell |
8,709
-1,385
| -14% | -$292K | 0.04% | 548 |
|
|
2023
Q2 | $2.09M | Buy |
10,094
+8,474
| +523% | +$1.64M | 0.05% | 542 |
|
|
2023
Q1 | $319K | Buy |
+1,620
| New | +$333K | 0.01% | 1472 |
|
|
2022
Q4 | – | Sell |
-40,750
| Closed | -$7.17M | – | 2229 |
|
|
2022
Q3 | $7.17M | Sell |
40,750
-10,336
| -20% | -$2.12M | 0.18% | 94 |
|
|
2022
Q2 | $10.3M | Buy |
51,086
+16,428
| +47% | +$3.5M | 0.27% | 46 |
|
|
2022
Q1 | $7.85M | Buy |
34,658
+13,838
| +66% | +$3.25M | 0.18% | 108 |
|
|
2021
Q4 | $5.62M | Buy |
20,820
+11,247
| +117% | +$2.78M | 0.13% | 172 |
|
|
2021
Q3 | $2.31M | Sell |
9,573
-1,010
| -10% | -$255K | 0.06% | 396 |
|
|
2021
Q2 | $2.51M | Buy |
10,583
+6,319
| +148% | +$1.44M | 0.08% | 304 |
|
|
2021
Q1 | $934K | Sell |
4,264
-20,874
| -83% | -$4.19M | 0.04% | 631 |
|
|
2020
Q4 | $4.4M | Buy |
25,138
+9,233
| +58% | +$1.59M | 0.16% | 109 |
|
|
2020
Q3 | $2.57M | Buy |
15,905
+5,054
| +47% | +$801K | 0.16% | 161 |
|
|
2020
Q2 | $1.55M | Buy |
10,851
+7,302
| +206% | +$1.01M | 0.11% | 256 |
|
|
2020
Q1 | $385K | Sell |
3,549
-19,024
| -84% | -$2.74M | 0.03% | 507 |
|
|
2019
Q4 | $3.28M | Sell |
22,573
-1,604
| -7% | -$232K | 0.29% | 80 |
|
|
2019
Q3 | $3.49M | Buy |
+24,177
| New | +$3.53M | 0.32% | 71 |
|
|
2018
Q3 | – | Sell |
-2,413
| Closed | -$372K | – | 873 |
|
|
2018
Q2 | $372K | Sell |
2,413
-761
| -24% | -$115K | 0.03% | 414 |
|
|
2018
Q1 | $441K | Buy |
+3,174
| New | +$466K | 0.05% | 358 |
|
|
2017
Q2 | – | Sell |
-2,558
| Closed | -$315K | – | 759 |
|
|
2017
Q1 | $315K | Buy |
+2,558
| New | +$303K | 0.06% | 412 |
|
|
2016
Q3 | – | Sell |
-2,717
| Closed | -$304K | – | 761 |
|
|
2016
Q2 | $304K | Buy |
+2,717
| New | +$292K | 0.12% | 245 |
|
Other funds holding LH
Boothbay Fund Management's LH Position: Q2 2026 in Review
Boothbay Fund Management sold out of Labcorp (LH) in Q2 2026, closing a stake of 1,345 shares — an estimated $359K sold.
Boothbay Fund Management first reported a position in LH in Q2 2016 and held it in 23 quarters. The position peaked at $10.3M in Q2 2022. 1,060 funds tracked by Wall St. Rank hold LH as of Q2 2026.
- Boothbay Fund Management reported no remaining Labcorp position as of Q2 2026 after selling out during the quarter.
- Boothbay Fund Management sold 1,345 Labcorp shares in Q2 2026, an estimated $359K.
- Boothbay Fund Management first reported a position in Labcorp in Q2 2016 and held it in 23 quarters.
- Boothbay Fund Management's Labcorp position peaked at $10.3M in Q2 2022.
- 1,060 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.
Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.